Literature DB >> 25681853

Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.

Richard A Anderson1, Ellen Anckaert2, Ernesto Bosch3, Didier Dewailly4, Cheryl E Dunlop5, Daniel Fehr6, Luciano Nardo7, Johan Smitz2, Kelton Tremellen8, Barbara Denk9, Andrea Geistanger9, Martin Hund10.   

Abstract

OBJECTIVE: To evaluate a new fully automated assay measuring antimüllerian hormone (AMH; Roche Elecsys) against antral follicle count in women of reproductive age.
DESIGN: Prospective cohort study.
SETTING: Hospital infertility clinics and academic centers. PATIENT(S): Four hundred fifty-one women aged 18 to 44 years, with regular menstrual cycles. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): AMH and antral follicle count (AFC) determined at a single visit on day 2-4 of the menstrual cycle. RESULT(S): There was a statistically significant variance in AFC but not in AMH between centers. Both AFC and AMH varied by age (overall Spearman rho -0.50 for AFC and -0.47 for AMH), but there was also significant between-center variation in the relationship between AFC and age but not for AMH. There was a strong positive correlation between AMH and AFC (overall spearman rho 0.68), which varied from 0.49 to 0.87 between centers. An agreement table using AFC cutoffs of 7 and 15 showed classification agreement in 63.2%, 56.9% and 74.5% of women for low, medium, and high groups, respectively. CONCLUSION(S): The novel fully automated Elecsys AMH assay shows good correlations with age and AFC in women of reproductive age, providing a reproducible measure of the growing follicle pool.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimüllerian hormone; antral follicle count; ovarian follicle; ovarian reserve; reproductive life span

Mesh:

Substances:

Year:  2015        PMID: 25681853     DOI: 10.1016/j.fertnstert.2015.01.004

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  Anti-Müllerian hormone is all you need: an assisted reproductive technology perspective in diagnosing polycystic ovary syndrome.

Authors:  Kate McCullough; William Ledger
Journal:  Womens Health (Lond)       Date:  2016-05-11

2.  Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.

Authors:  Massimo Giusti; Miranda Mittica; Paola Comite; Claudia Campana; Stefano Gay; Michele Mussap
Journal:  Endocrine       Date:  2018-01-04       Impact factor: 3.633

3.  Reliability of AMH and AFC measurements and their correlation: a large multicenter study.

Authors:  Philippe Arvis; Catherine Rongières; Olivier Pirrello; Philippe Lehert
Journal:  J Assist Reprod Genet       Date:  2022-03-03       Impact factor: 3.357

Review 4.  Elecsys(®) AMH Assay: A Review in Anti-Müllerian Hormone Quantification and Assessment of Ovarian Reserve.

Authors:  Emma D Deeks
Journal:  Mol Diagn Ther       Date:  2015-08       Impact factor: 4.074

Review 5.  Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review.

Authors:  Agathe Dumont; Geoffroy Robin; Sophie Catteau-Jonard; Didier Dewailly
Journal:  Reprod Biol Endocrinol       Date:  2015-12-21       Impact factor: 5.211

6.  Anti-müllerian hormone levels are reduced in women living with human immunodeficiency virus compared to control women: a case-control study from Copenhagen, Denmark.

Authors:  Maria Wessman; Anne-Sofie Korsholm; Janne Gasseholm Bentzen; Anders Nyboe Andersen; Magnus Glindvad Ahlström; Terese Lea Katzenstein; Nina Weis
Journal:  J Virus Erad       Date:  2018-04-01

7.  Derailing individualized ovarian stimulation.

Authors:  Scott M Nelson; Richard A Anderson
Journal:  Hum Reprod       Date:  2018-05-01       Impact factor: 6.918

Review 8.  Challenges in Measuring AMH in the Clinical Setting.

Authors:  Hang Wun Raymond Li; David Mark Robertson; Chris Burns; William Leigh Ledger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-24       Impact factor: 5.555

9.  Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.

Authors:  Kelly-Anne Phillips; Ian M Collins; Roger L Milne; Sue Anne McLachlan; Michael Friedlander; Martha Hickey; Catharyn Stern; John L Hopper; Richard Fisher; Gordon Kannemeyer; Sandra Picken; Charmaine D Smith; Thomas W Kelsey; Richard A Anderson
Journal:  Hum Reprod       Date:  2016-05       Impact factor: 6.918

10.  The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.

Authors:  R A Anderson; J Mansi; R E Coleman; D J A Adamson; R C F Leonard
Journal:  Eur J Cancer       Date:  2017-11-05       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.